Oncolytics Biotech ONCY 深 沪
等待开盘 12-18 09:30:00 美东时间
1.01
-0.030
-2.88%
华盛通- 最 高1.06
- 今 开1.04
- 成交量 49.16万股
- 最 低 0.99
- 昨 收 1.04
- 总市值 1.07亿
- 52周最高 1.51
- 市盈率 静 --
- 换手率 0.46%
- 52周最低 0.3258
- 委 比 -50.00%
- 总股本 1.06亿
- 历史最高 6.037
- 量 比 0.81
- 振 幅 6.73%
- 历史最低 0.3258
- 每 手 1
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 16, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Gastrointestinal cancers that once resisted checkpoint inhibitors ...
12-17 02:17
Oncolytics Biotech Announces Clinical And Translational Findings Supporting Development Of Pelareorep In Second-Line mCRC, Specifically In Patients With KRAS- MSS Disease
33% ORR achieved in second-line KRAS-mutant MSS colorectal cancer—triple historical response rates for Avastin + FOLFIRI of 6-11%Translational analysis shows pelareorep enhances KRAS-mutant–specific T-cell activity,
12-16 22:06
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immu...
12-12 23:47
Oncolytics Biotech Plans Jurisdiction Shift to Nevada
An announcement from Oncolytics Biotech ( ($ONCY) ) is now available. Oncolytic...
12-10 07:38
Oncolytics Biotech GAAP EPS of -C$0.14
Oncolytics Biotech (ONCY) press release: Q3 GAAP EPS of -C$0.14. We ended the third quarter of 2025 with cash and cash equivalents of C$12.35M. More on Oncolytics Biotech Oncolytics, FDA agree on phas...
11-24 22:18
Oncolytics Biotech Aligns with FDA for Pivotal Pancreatic Cancer Study
Oncolytics Biotech ( ($ONCY) ) has shared an update. Oncolytics Biotech Inc. an...
11-19 22:28
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Raises Price Target to $10
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Oncolytics Biotech (NASDAQ:ONCY) with a Buy and raises the price target from $5 to $10.
11-17 20:16
Oncolytics Biotech Plans Jurisdiction Shift to Nevada
Oncolytics Biotech ( ($ONCY) ) has shared an update. Oncolytics Biotech Inc. ha...
10-20 21:39
Oncolytics Biotech Plans Move From Canada To U.S. With Proposed Domestication To Nevada
Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed a registration statement on Form F-4 with the
10-20 21:12
